New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
15:12 EDTSCMPSucampo says FDA approves addition of Nitto Medic as Rescula production site
Sucampo Pharmaceuticals disclosed in a regulatory filing that on July 15 the company received an approval letter from the FDA to its prior approval supplement in response to FDAs review of the revised Drug Master File of R-Tech Ueno. The approval provides for the addition of Nitto Medic of Toyama, Japan as a new production site for Rescula 0.15%. "The company has adequate supply of RESCULA to be able to supply the U.S. market into the first quarter of 2015," Sucampo added.
News For SCMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
07:13 EDTSCMPSucampo repeats FY15 EPS view 55c-65c, consensus 58c
Sees FY15 net income $25M-$30M. Comments from slides that will be presented at the 14th Annual Needham Healthcare Conference.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use